15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Balchem Corporation, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $5.16 to $162.00 (about 31.4x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $83.58 sits 50% below the current $165.70. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.50 next quarter toward $6.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Balchem Corporation.
As of Jul, 1 of 2 firms rate BCPC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BCPC EPS & revenue forecast
EPS · NEXT QUARTER
$1.50
Range $1.50 – $1.51 · 2 analysts · +11% YoY
Next period, 2 analysts expect Balchem Corporation to earn $1.50 a share (range $1.50 – $1.51), versus $1.35 a year earlier. Full-year consensus is $5.68, growing to $6.11 the year after.
REVENUE · NEXT QUARTER
$284.5M
Range $281.5M – $287.6M · 2 analysts · +6% YoY
Revenue is expected to reach $284.5M (range $281.5M – $287.6M), +6.3% year-over-year. Full-year consensus is $1.1B, rising to $1.2B next year.
Top analysts covering Balchem Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BCPC.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Buy
$5.16-96.9% to target
Overall win rate
37%
+ Follow
#2
AC
Artem Chubarov
Redburn Atlantic
Hold
$162.00-2.2% to target
Coverage
—
+ Follow
#3
AC
Artem Chubarov
Rothschild & Co
Hold
$162.00-2.2% to target
Coverage
—
+ Follow
BCPC stock forecast FAQ
What is BCPC's average 12-month price target?+
The 2 analysts with a live target average $83.58 for Balchem Corporation over the next 12 months, ranging from a $162.00 high to a $5.16 low.
Is BCPC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BCPC?+
The Street-high target is $162.00 (Rothschild & Co), and the Street-low is $5.16 (HC Wainwright & Co.). The average of all 2 active targets is $83.58.
How many Wall Street analysts cover BCPC?+
2 analysts have an active rating on Balchem Corporation, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BCPC?+
Among analysts who currently cover BCPC, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #249). Their current call is Buy with a $5.16 target.
What is Balchem Corporation's projected EPS for next quarter?+
The consensus estimate is $1.50 per share (range $1.50 – $1.51) across 2 analysts. Full-year EPS is projected at $5.68, rising to $6.11 the following year.
How much revenue is Balchem Corporation expected to report next quarter?+
Consensus revenue is $284.5M (range $281.5M – $287.6M). Full-year revenue is projected at $1.1B, growing to $1.2B next year.
Have analysts been upgrading or downgrading BCPC lately?+
As of Jul, 1 of 2 firms rate BCPC a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BCPC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
